Literature DB >> 7406527

[Influence of chloroquine on the hexachlorobenzene-induced porphyria. Investigations in the skin, liver, and urine (author's transl)].

W Vizethum, K Bolsen, K Simon, K Weber, G Goerz.   

Abstract

Rats were fed with a diet containing hexachlorobenzene (HCB) for about 60 days. At this time the porphyria was manifst as shown by significantly elevated porphyrins. Thereafter, chloroquine (CQ) was additionally given over a period of at lest 6 weeks. At the end of the experiment the urinary porphyrin excretion and the porphyrin content in lijver and skin were diminished in HCB-CQ-treated animals by about 50% compared to the HCB controls. The relative porphyrin distribution pattern was not influenced by CQ. In a further investigation the prophylactic effect of CQ could be demonstrated. Rats given CQ simultaneously from the beginning of the HCB feeding showed a significantly delayed onset of porphyria. It is concluded from our results that CQ does not only form complexes with porphyrins during the treatment of th HCB porphyria. We rather assume an effect of CQ on the metabolism of iron.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7406527     DOI: 10.1007/bf00569098

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  19 in total

1.  Porphyrin concentration from ultraviolet extinction; a note on the calculation.

Authors:  T K WITH
Journal:  Scand J Clin Lab Invest       Date:  1955       Impact factor: 1.713

2.  Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.

Authors:  G Swanbeck; G Wennersten
Journal:  Br J Dermatol       Date:  1977-07       Impact factor: 9.302

3.  Prophyrin metabolism in experimental hepatic siderosis in the rat. II. Combined effect of iron overload and hexachlorobenzene.

Authors:  J J Taljaard; B C Shanley; W M Deppe; S M Joubert
Journal:  Br J Haematol       Date:  1972-10       Impact factor: 6.998

4.  The molecular basis of the action of chloroquine in porphyria cutanea tarda.

Authors:  P L Scholnick; J Epstein; H S Marver
Journal:  J Invest Dermatol       Date:  1973-10       Impact factor: 8.551

5.  Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria.

Authors:  J J Taljaard; B C Shanley; E G Stewart-Wynne; W M Deppe; S M Joubert
Journal:  Br J Dermatol       Date:  1972-09       Impact factor: 9.302

6.  Analytical and preparative thin-layer chromatography of porphyrin methyl esters.

Authors:  M Doss
Journal:  Z Klin Chem Klin Biochem       Date:  1970-05

7.  [Separation, isolation and determination of proto-, copro-, pentacarboxy-, hexacarboxy-, heptacarboxy- and uroporphyrin].

Authors:  M Doss
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1969-04

8.  [Porphyria cutanea tarda: possible treatment and its results (author's transl)].

Authors:  G Goerz; T Krieg
Journal:  Dtsch Med Wochenschr       Date:  1978-08-25       Impact factor: 0.628

9.  Treatment of porphyria cutanea tarda by phlebotomy.

Authors:  H Ippen
Journal:  Semin Hematol       Date:  1977-04       Impact factor: 3.851

10.  Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.

Authors:  G H Elder; G B Lee; J A Tovey
Journal:  N Engl J Med       Date:  1978-08-10       Impact factor: 91.245

View more
  1 in total

1.  Influence of chloroquine on the porphyrin metabolism.

Authors:  G Goerz; K Bolsen; H Merk
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.